 MIDAS Multicenter Isradipine/Diuretic Atherosclerosis Study Design features baseline data Multicenter Isradipine/Diuretic Atherosclerosis Study MIDAS randomized double-blind active-control trial effectiveness treatment regimens control hypertension rate progression early extracranial carotid artery atherosclerosis hypertensive patients double-blind treatment regimens mg isradipine mg mg hydrochlorothiazide Patients blood pressure regimens addition tolerated dose blinded drug mg open-label enalapril MIDAS study patients treatment isradipine hydrochlorothiazide Inclusion criteria men women age years presence atherosclerotic lesion extracranial carotid artery B-mode ultrasound scanning maximum thickness mm average diastolic blood pressure mm Hg low-density lipoprotein levels mg/dL assessment patient blood pressure side effects months B-mode ultrasound examination carotid arteries baseline months electrocardiogram baseline year brief quality-of-life assessment baseline year